Top 5 Ways Life Sciences Companies Can Prepare for an FDA Inspection
Top 5 Ways Life Sciences Companies Can Prepare for an FDA Inspection As FDA resources tighten and regulatory expectations evolve, inspection readiness has never been more critical. Life sciences companies – whether in pharmaceuticals, biotech, or medical devices –...
Building a Scalable Identity and Access Management Program with SailPoint
Building a Scalable Identity and Access Management Program with SailPoint Background: A leading biopharmaceutical company partnered with Osprey Life Sciences to strengthen its Identity and Access Management (IAM) capabilities. With a growing and diverse...
Measuring the Impact of FDA Personnel Cuts in 2025
Measuring the Impact of FDA Personnel Cuts in 2025 How Staff Reductions Are Disrupting Drug Reviews and Regulatory Oversight The 2025 FDA personnel cuts are already sending shockwaves through the drug approval pipeline, with mounting evidence that reduced staffing is...
Accelerating Transformation in Global Regulatory Affairs
Accelerating Transformation in Global Regulatory Affairs Background: Recently, a top-tier biopharmaceutical company’s Global Regulatory Affairs (GRA) division launched a strategic transition to shift regulatory operations from one vendor to another. The move was part...